<p><b>C</b>hange from baseline in health status was not significantly different between participants in the group visits or the standard care arms.</p
Baseline characteristics compared between the drug-free remission group and the non-remission group....
The percentage of patients with VA gained more than two lines, VA stable, and VA dropped more than t...
Baseline characteristics and medications during the index hospitalization: PCI group versus CABG gro...
<p>Subgroup Analyses for the mean difference of HbA1c in the pharmacist intervention compared with u...
Comparison of laboratory parameters of SFTS patients in the HPE and AP groups.</p
<p>Differences and 95%CI are derived from repeated measurements models (including main effects for t...
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
Background The SF-36 is a generic health status measure which has gained popularity as a measure of ...
<p>NMF, nalmefene; PBO, placebo; SF-36 PCS, Short-Form health survey-36 physical component summary. ...
Comparison of laboratory parameters of SFTS patients in the survivor and non-survivor groups.</p
<p>SD: Standard deviation. #PC patient samples were limited to treatment naïve samples only for this...
<p>A, B represents the change from baseline in the WHO test vs placebo by treatment and HIV-status. ...
<p>Comparison of recipient demographics, OLT-related parameters, and hepatitis C viral parameters be...
*<p>Significant differences were observed between any two groups.</p>#<p>Significant differences wer...
Baseline characteristics compared between the drug-free remission group and the non-remission group....
The percentage of patients with VA gained more than two lines, VA stable, and VA dropped more than t...
Baseline characteristics and medications during the index hospitalization: PCI group versus CABG gro...
<p>Subgroup Analyses for the mean difference of HbA1c in the pharmacist intervention compared with u...
Comparison of laboratory parameters of SFTS patients in the HPE and AP groups.</p
<p>Differences and 95%CI are derived from repeated measurements models (including main effects for t...
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
Background The SF-36 is a generic health status measure which has gained popularity as a measure of ...
<p>NMF, nalmefene; PBO, placebo; SF-36 PCS, Short-Form health survey-36 physical component summary. ...
Comparison of laboratory parameters of SFTS patients in the survivor and non-survivor groups.</p
<p>SD: Standard deviation. #PC patient samples were limited to treatment naïve samples only for this...
<p>A, B represents the change from baseline in the WHO test vs placebo by treatment and HIV-status. ...
<p>Comparison of recipient demographics, OLT-related parameters, and hepatitis C viral parameters be...
*<p>Significant differences were observed between any two groups.</p>#<p>Significant differences wer...
Baseline characteristics compared between the drug-free remission group and the non-remission group....
The percentage of patients with VA gained more than two lines, VA stable, and VA dropped more than t...
Baseline characteristics and medications during the index hospitalization: PCI group versus CABG gro...
DOI
Add to ORKG